Prostatis Group LLC has filed its 13F form on July 25, 2025 for Q2 2025 where it was disclosed a total value porftolio of $349 Billion distributed in 156 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Invesco Qqq Trust, Series 1 with a value of $34.3B, Amplify ETF Tr Amplify Cwp Enh with a value of $18.8B, Spdr S&P 500 ETF Trust with a value of $17.7B, Spdr Dow Jones Industrial Average ETF Trust with a value of $17.2B, and Thor Finl Technologies Tr with a value of $13.1B.

Examining the 13F form we can see an increase of $32.4B in the current position value, from $317B to 349B.

Prostatis Group LLC is based out at Hanover, MD

Below you can find more details about Prostatis Group LLC portfolio as well as his latest detailed transactions.

Portfolio value $349 Billion
ETFs: $269 Billion
Technology: $14.7 Billion
Consumer Cyclical: $9.14 Billion
Communication Services: $7.9 Billion
Industrials: $5.85 Billion
Financial Services: $5.5 Billion
Energy: $3.05 Billion
Consumer Defensive: $2.17 Billion
Other: $3.96 Billion

Stock Holdings Table Market Cap. of $300 Millions to $2 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 156
  • Current Value $349 Billion
  • Prior Value $317 Billion
  • Filing
  • Period Q2 2025
  • Filing Date July 25, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 27 stocks
  • Additional Purchases 50 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 78 stocks
Track This Portfolio

Track Prostatis Group LLC Portfolio

Follow Prostatis Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prostatis Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prostatis Group LLC with notifications on news.